VistaGen announces annual shareholder meeting

• VistaGen Therapeutics will hold its 2026 annual stockholders meeting virtually on Sept. 10, 2026.
• Shareholders will vote to elect four director nominees: Jon S. Saxe, Ann M. Cunningham, Shawn K. Singh, Douglas J. Williamson.
• Advisory vote scheduled on executive compensation for named executive officers.
• Ratification vote set on KPMG as independent registered public accounting firm for the fiscal year ending March 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-051404), on July 31, 2026, and is solely responsible for the information contained therein.